phenyl acetate has been researched along with Coronary Thrombosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antrilli, TM; Crandall, DL; Elokdah, H; Friedrichs, GS; Hennan, JK; Hreha, A; Ji, A; Leal, M; Morgan, GA; Swillo, RE | 1 |
Hornberger, W; Kirchengast, M; Rübsamen, K | 1 |
Fitzgerald, DJ; Murphy, NP; Pratico, D | 1 |
3 other study(ies) available for phenyl acetate and Coronary Thrombosis
Article | Year |
---|---|
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
Topics: Acetates; Animals; Bleeding Time; Blood Pressure; Coronary Circulation; Coronary Thrombosis; Dogs; Endpoint Determination; Fibrinolysis; Fibrinolytic Agents; Heart Rate; Hemostasis; Indoleacetic Acids; Indoles; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Ventricular Remodeling | 2005 |
Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
Topics: Acetates; Ancrod; Animals; Antithrombins; Benzamides; Coronary Thrombosis; Dogs; Female; Fibrinolytic Agents; Hemodynamics; Hirudins; Male; Platelet Glycoprotein GPIIb-IIIa Complex | 1995 |
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine | 1998 |